Kynam Capital Management, LP Liquidia Corp Transaction History
Kynam Capital Management, LP
- $837 Million
- Q2 2025
A detailed history of Kynam Capital Management, LP transactions in Liquidia Corp stock. As of the latest transaction made, Kynam Capital Management, LP holds 200,047 shares of LQDA stock, worth $4.82 Million. This represents 0.3% of its overall portfolio holdings.
Number of Shares
200,047
Previous 633,802
68.44%
Holding current value
$4.82 Million
Previous $9.35 Million
73.34%
% of portfolio
0.3%
Previous 0.79%
Shares
13 transactions
Others Institutions Holding LQDA
# of Institutions
209Shares Held
47.5MCall Options Held
1.61MPut Options Held
1.15M-
Black Rock Inc. New York, NY4.24MShares$102 Million0.0% of portfolio
-
Farallon Capital Management LLC San Francisco, CA4.24MShares$102 Million0.24% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.59MShares$86.6 Million0.0% of portfolio
-
Findell Capital Management LLC New York, NY3MShares$72.3 Million18.2% of portfolio
-
Opaleye Management Inc. Boston, MA2.48MShares$59.6 Million7.37% of portfolio
About Liquidia Corp
- Ticker LQDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,362,300
- Market Cap $1.55B
- Description
- Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...